Cabazitaxel-XRP6258
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cabazitaxel-XRP6258, covering 2017-05-24 to 2017-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer [Phase 2]